Abstract:Background The disease-associated non-coding variants identified by genome-wide association studies (GWASs) were enriched in open chromatin regions (OCRs) and implicated in gene regulation. Genetic variants in OCRs thus may exert regulatory functions and contribute to non-small cell lung cancer (NSCLC) susceptibility. Objective To fine map potential functional variants in GWAS loci that contribute to NSCLC predisposition using chromatin accessibility and histone modification data and explore their functions by population study and biochemical experimental analyses. Methods We mapped the chromatin accessible regions of lung tissues using data of assay for transposase-accessible chromatin using sequencing (ATAC-seq) in The Cancer Genome Atlas (TCGA) and prioritized potential regulatory variants within lung cancer GWAS loci by aligning with histone signatures using data of chromatin immunoprecipitation assays followed by sequencing (ChIP-seq) in the Encyclopedia of DNA Elements (ENCODE). A two-stage case–control study with 1,830 cases and 2,001 controls was conducted to explore the associations between candidate variants and NSCLC risk in Chinese population. Bioinformatic annotations and biochemical experiments were performed to further reveal the potential functions of significant variants. Results Sixteen potential functional single-nucleotide polymorphisms (SNPs) were selected as candidates from bioinformatics analyses. Three variants out of the 16 candidate SNPs survived after genotyping in stage 1 case–control study, and only the results of SNP rs13064999 were successfully validated in the analyses of stage 2 case–control study. In combined analyses, rs13064999 was significantly associated with NSCLC risk [additive model; odds ratio (OR) = 1.17; 95%CI, 1.07–1.29; p = 0.001]. Functional annotations indicated its potential enhancer bioactivity, and dual-luciferase reporter assays revealed a significant increase in luciferase activity for the reconstructed plasmid with rs13064999 A allele, when compared to the one with wild-type G allele ( p A549 < 0.001, p SK-MES-1 = 0.004). Further electrophoretic mobility shift assays (EMSA) and super-shift assays confirmed a stronger affinity of HP1γ for the binding motif containing SNP rs13064999 A allele. Conclusion These findings suggested that the functional variant rs13064999, identified by the integration of ATAC-seq and ChIP-seq data, contributes to the susceptibility of NSCLC by affecting HP1γ binding, while the exact biological mechanism awaits further exploration.

A Functional Variant at 19q13.3, Rs967591g>a, is Associated with Shorter Survival of Early-Stage Lung Cancer

Supplementary Figure 1 from A Functional Variant at 19q13.3, Rs967591g>a, is Associated with Shorter Survival of Early-Stage Lung Cancer

A Functional Polymorphism on Chromosome 15q25 Associated with Survival of Early Stage Non–Small-Cell Lung Cancer

Supplementary Table 1 from A Functional Variant at 19q13.3, Rs967591g>a, is Associated with Shorter Survival of Early-Stage Lung Cancer

Supplementary Figure 2 from A Functional Variant at 19q13.3, Rs967591g>a, is Associated with Shorter Survival of Early-Stage Lung Cancer

Supplementary Figure 3 from A Functional Variant at 19q13.3, Rs967591g>a, is Associated with Shorter Survival of Early-Stage Lung Cancer

A Genetic Polymorphism In Pre-Mir-27a Confers Clinical Outcome Of Non-Small Cell Lung Cancer In A Chinese Population

Analysis of Genetic Variants and the Cerna Network of Mir-9 in Non-Small Cell Lung Cancer

Genetic variations in <i>SLC3A2/CD98</i> gene as prognosis predictors in non‐small cell lung cancer

Genetic variations in SLC3A2/CD98 gene as prognosis predictors in non-small cell lung cancer.

Functional Flt1 Genetic Variation is A Prognostic Factor for Recurrence in Stage I-Iii Non-Small-Cell Lung Cancer

Genetic Variants Of Chrna5-A3 And Chrnb3-A6 Predict Survival Of Patients With Advanced Non-Small Cell Lung Cancer

Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.

Novel Genetic Variants of SYK and ITGA1 Related Lymphangiogenesis Signaling Pathway Predict Non-Small Cell Lung Cancer Survival.

A Functional Variant in Mir-155 Regulation Region Contributes to Lung Cancer Risk and Survival

A Functional Polymorphism in Accessible Chromatin Region Confers Risk of Non-Small Cell Lung Cancer in Chinese Population

Abstract A3: MicroRNA-related Polymorphisms Are Associated with Clinical Outcomes in Early Stage Non-Small Cell Lung Cancer Patients

Novel Genetic Variants in Genes of the Fc Gamma Receptor-Mediated Phagocytosis Pathway Predict Non-Small Cell Lung Cancer Survival.

The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients

Genetic Variations In Apoptosis Pathway Are Associated With Survival In Late Stage Non-Small Cell Lung Cancer

Genetic Variants in the Human Leukocyte Antigen Region and Survival of Chinese Patients with Non-Small Cell Lung Carcinoma.